Large companies that participate in the bio-economy are replacing traditional technologies with modern synthesis and machine learning driven techniques. This modern approach coupled with machine learning has opened the door for a radical transformation of biology and a rapid expansion of potential applications. This increased demand requires a secure, scalable, interoperable, protocol-driven platform that can span multiple users working on multiple projects across large, geographically distributed organizations. These new approaches are pushing companies to update their product development methods and IP strategies to maintain their lead and competitive advantage. 

TeselaGen is deploying the first solution that incorporates state of the art AI-enabled information technology for biotechnology as a secure enterprise operating system. We make the development of bio-based products faster and easier. We provide a highly secure enterprise quality operating system that our customers can use right away, instead of spending millions to develop it themselves.

By working with TeselaGen, you replace costly and time-consuming traditional methods for development of biotech products in pharma, ag-tech, and industrial biotech with a data driven discovery platform that enables the development of new high-performance bioproducts faster than ever before. For example, Dow AgroSciences has used the TeselaGen platform to complete a previously intractable multi-year crop protection biomolecule design/build/test project in just a few months, increasing DOW’s target hit rate by 10-fold. Arzeda uses our platform to guide its design/build process for novel enzymes, LanzaTech uses our platform to develop high value chemicals from waste gas, while Amgen exploited our capabilities for antibody production.